St. Barnabas Medical Center, Livingston, NJ   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Livingston NJ United States (1865)

Organization Overview

First Clinical Trial
1998
NCT00003717
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Robert Wood Johnson Barnabas Health | RWJ Barnabas Health at Jersey City Medical Center | St. Barnabas Medical Center | St. Barnabas Medical Center, Livingston, New Jersey | St. Barnabas Medical Center, Livingston, NJ 07039

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 2)

Anemia, Sickle Cell (Phase 2)

Communicable Diseases (Phase 2)

Emergencies (Phase 2)

Endometritis (Phase 2)

Infections (Phase 2)

Pain, Postoperative (Phase 4)

Prostatic Neoplasms (Phase 2)

Puberty, Precocious (Phase 3)

Wound Infection (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 10